Clinical

Dataset Information

0

Study for Validation of Immunological Biomarkers in Patients With Metastatic Colorectal Cancer


ABSTRACT: The investigators recently identified promiscuous HLA-DR-derived epitopes from the human telomerase reverse transcriptase (TERT) called universal cancer peptides (UCP), to study tumor-specific CD4+ T cell responses. The investigators found high frequency of naturally occuring UCP-specific TH1 cells in long term survival of metastatic colorectal cancer (CRC) previously treated by 5 fluoro-uracil -oxaliplatin (Folfox) +/- bevacizumab regiment (Godet et al. OncoImmunology 2012 and unpublished data). Epitopes-CRC02 is a French prospective multicenter study which will evaluate the post chemotherapy and post surgery modulation of host tumor-specific CD4 TH1 cell responses in metastatic colorectal cancer patients and their correlation with progression-free survival.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2218590 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2014-12-04 | E-GEOD-63825 | biostudies-arrayexpress
2024-09-02 | BIOMD0000000663 | BioModels
| phs001805 | dbGaP
2016-06-01 | E-GEOD-73118 | biostudies-arrayexpress
| 2096816 | ecrin-mdr-crc
2022-08-26 | PXD036319 | Pride
| 2173055 | ecrin-mdr-crc
2020-11-08 | GSE161037 | GEO
2018-06-30 | E-MTAB-6156 | biostudies-arrayexpress
2015-06-09 | GSE51904 | GEO